Clinical Trials Directory

Trials / Completed

CompletedNCT03841084

Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial

Blend to Limit oxygEN in ECMO: a ranDomised controllEd Registry Trial The BLENDER Trial - A Phase II Multicentre Randomised Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Australian and New Zealand Intensive Care Research Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine in patients requiring venoarterial (V-A) ECMO, whether the use of a conservative as compared with liberal oxygen strategy, results in a greater number of ICU-free days at day 28.

Detailed description

Extracorporeal membrane oxygenation (ECMO) can be a lifesaving procedure for the sickest patients in the Intensive Care Unit (ICU) who are at risk of death from severe cardiac and respiratory failure. ECMO is a device which pumps blood out of the body and returns it back after adding oxygen and removing carbon dioxide. While potentially life-saving, ECMO is associated with high use of critical care resources and increased risk of adverse outcomes in survivors. The BLENDER Trial is a multicentre trial in ECMO patients to determine whether a conservative oxygen strategy during ECMO reduces ICU length of stay and improves patient outcomes compared to a liberal oxygen strategy. Both strategies are currently standard practice worldwide, however, there is no consensus to which strategy is better for our patients. This trial aims to utilise an existing intensive care registry and will recruit 300 patients with life threatening acute cardiac or respiratory failure. If the BLENDER Trial confirms that one oxygen management strategy is more effective than the other, its findings may improve the lives of critically ill Australians and inform clinical practice worldwide.

Conditions

Interventions

TypeNameDescription
DRUGOxygenConservative oxygen management strategy- reduces oxygen on the inoblender in the ECMO circuit. Liberal oxygen management strategy - does not reduce the oxygen on the inoblender via the ECMO circuit

Timeline

Start date
2019-09-18
Primary completion
2023-06-03
Completion
2023-07-01
First posted
2019-02-15
Last updated
2024-08-09

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT03841084. Inclusion in this directory is not an endorsement.